These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 985619)

  • 1. Combination chemotherapy with adriamycin and cis-diamminedichloroplatinum in patients with neoplastic diseases.
    Vogl S; Ohnums T; Perloff M; Holland JF
    Cancer; 1976 Jul; 38(1):21-6. PubMed ID: 985619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
    Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
    Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin plus cisplatin in the treatment of apudomas.
    Sridhar KS; Holland JF; Brown JC; Cohen JM; Ohnuma T
    Cancer; 1985 Jun; 55(11):2634-7. PubMed ID: 4039625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group study.
    Gagliano R; Levin H; El-Bolkainy MN; Wilson HE; Stephens RL; Fletcher WS; Rivkin SE; O'Bryan RM; Coltman CA; Saiki JH; Stuckey WJ; Balducci L; Bonnet JD; Dixon DO
    Am J Clin Oncol; 1983 Apr; 6(2):215-8. PubMed ID: 6681934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
    Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
    Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract.
    Khandekar JD; Elson PJ; DeWys WD; Slayton RE; Harris DT
    J Clin Oncol; 1985 Apr; 3(4):539-45. PubMed ID: 3884746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.
    Briscoe KE; Pasmantier MW; Ohnuma T; Kennedy BJ
    Cancer Treat Rep; 1978 Dec; 62(12):2027-30. PubMed ID: 751711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adriamycin in chemotherapy of solid tumors].
    Lovisetto P; Pochettino G; Biarese V
    Minerva Med; 1975 May; 66(35):1653-63. PubMed ID: 1128811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of combination chemotherapy with cis-diamminedichloroplatinum for advanced genitourinary carcinoma].
    Nakatsu H; Nishimoto K; Moriyama H; Ehara S; Igawa M; Ishino T; Kodama M; Fujii M; Ukai R; Nihira H
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):702-9. PubMed ID: 6892199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin and cis-dichlorodiammineplatinum in nonresectable and metastatic carcinoma of the lung.
    Morris RW; Brubaker LH; Kardinal CG; Carolla RL; Perry MC
    Cancer Clin Trials; 1979; 2(1):37-41. PubMed ID: 229982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
    Lloyd RE; Jones SE; Salmon SE; Durie BG; McMahon LJ
    Cancer Treat Rep; 1976 Jan; 60(1):77-83. PubMed ID: 1000520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
    Schütte J; Niederle N; Grunenberg B; Krischke W; Seeber S; Schmidt CG
    J Cancer Res Clin Oncol; 1984; 107(1):38-41. PubMed ID: 6583205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase of I trial of 4'-epi-Adriamycin.
    Schauer PK; Wittes RE; Gralla RJ; Casper ES; Young CW
    Cancer Clin Trials; 1981; 4(4):433-7. PubMed ID: 7318126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms.
    Ostrow S; Egorin MJ; Hahn D; Markus S; Leroy A; Chang P; Klein M; Bachur NR; Wiernik PH
    Cancer; 1980 Oct; 46(8):1715-21. PubMed ID: 7191768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
    Irino S; Fujita J; Yamaji Y; Futami H; Hashimoto Y; Bungo M; Iuchi Y; Kamei M; Nakamura H; Hata Y
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A; Gotoh A; Hara I; Gohji K; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Hamami G; Itani A
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
    Campbell M; Baker LH; Opipari M; Al-Sarraf M
    Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adriamycin, cisplatin and etoposide combination chemotherapy in non-small cell lung cancer].
    Yamaji Y; Fujita J; Kamei M; Futami H; Hashimoto Y; Bungo M; Nakamura H; Hata Y; Shiotani T; Irino S
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):601-6. PubMed ID: 1849390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
    Thigpen JT; Brady MF; Homesley HD; Malfetano J; DuBeshter B; Burger RA; Liao S
    J Clin Oncol; 2004 Oct; 22(19):3902-8. PubMed ID: 15459211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.